Mycophenolate mofetil in giant cell arteritis

Mycophenolate mofetil in giant cell arteritis

IntroductionGiant cell arteritis (GCA) is a systemic granulomatous vasculitis affecting the large arteries. Abnormal lymphocyte function has been noted as a pathogenic factor in GCA. Mycophenolate mofetil (MMF) inhibits inosine monophosphate dehydrogenase and is therefore a highly lymphocyte-specifi...

Full description

Bibliographic Details
Main Authors:	Anne Pankow, Sena Sinno, Thorsten Derlin, Marcus Hiss, Annette D. Wagner
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Medicine
Subjects:	Mycophenolate mofetil giant cell arteritis vasculitis case series imaging
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1254747/full

Similar Items

Mycophenolate mofetil and mycophenolic acid for the treatment of eosinophilic fasciitis: report of two cases and literature review
by: Ilse Andrea Moreno-Arquieta, et al.
Published: (2022-04-01)

Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01)

Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
by: David Dias-Polak, et al.
Published: (2019-01-01)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01)

Effectiveness and safety of mycophenolate mofetil and rituximab combination therapy for immune idiopathic myopathies
by: Corrado Campochiaro, et al.
Published: (2024-04-01)

The association of mycophenolate mofetil and human herpes virus infection
by: Jenny Sung Won Yun, et al.
Published: (2020-01-01)

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
by: Natalia Oleksik, et al.
Published: (2022-10-01)

Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis
by: Niyaz Mostafa, et al.
Published: (2022-01-01)

Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01)

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
by: Amit K. Reddy, et al.
Published: (2023-06-01)

Mycophenolate mofetil in the treatment of non-renal manifestations of systemic lupus erythematosus: recent insights
by: Ali SAHIN
Published: (2010-05-01)

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial
by: Fatemeh Hayati, et al.
Published: (2019-04-01)

Protective effect of melatonin and mycophenolate mofetil against nephrotoxicity induced by tacrolimus in wistar rats
by: Suleyman KOC, et al.
Published: (2021-11-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using <i>Ex Vivo</i> T Cell Function Assays
by: Aliede E. in ’t Veld, et al.
Published: (2023-05-01)

Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01)

Immunosuppression by Mycophenolate Mofetil Mitigates Intrarenal Angiotensinogen Augmentation in Angiotensin II-Dependent Hypertension
by: Ryousuke Satou, et al.
Published: (2022-07-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

International guidelines for the management of giant cell arteritis and polymyalgia rheumatica: The 2015 results
by: T. V. Beketova, et al.
Published: (2016-10-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients
by: Lan-Fang Li, et al.
Published: (2023-03-01)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
by: Olga Blagova, et al.
Published: (2023-07-01)

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil
by: Mumina Akthar, et al.
Published: (2023-06-01)

Mycophenolate Mofetil Versus Prednisone for Induction Therapy in Steroid-Sensitive Idiopathic Nephrotic Syndrome in Children: An Observational Study
by: Alexandra Mazo, et al.
Published: (2024-03-01)

Diagnostic accuracy of OGUS, Southend halo score and halo count in giant cell arteritis
by: Edoardo Conticini, et al.
Published: (2024-01-01)

Treatment of scleredema adultorum of Buschke with intravenous immunoglobulin and mycophenolate mofetil in a 14-year-old girl: a case report
by: Mehran Pournazari, et al.
Published: (2024-02-01)

Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis
by: Shuhei Yoshida, et al.
Published: (2023-02-01)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
by: Xiaohui Zhang, et al.
Published: (2023-07-01)

Case report: Kimura's disease with minimal degenerative glomerulopathy without eosinophil infiltration responds to mycophenolate mofetil treatment
by: Qing Han, et al.
Published: (2023-01-01)

Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis
by: Mirjam Kolev, et al.
Published: (2022-01-01)

Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases
by: Maria De Santis, et al.
Published: (2022-05-01)

Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013–2020
by: H. K. Skaug, et al.
Published: (2023-12-01)

A rare case of temporal arteritis in a young Indian male
by: Debaditya Roy, et al.
Published: (2023-01-01)

Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia
by: Mert Öztaş, et al.
Published: (2021-08-01)

Mycophenolate mofetil for autoimmune cytopenias in children: high rates of response in inborn errors of immunity
by: Rubén Berrueco, et al.
Published: (2023-10-01)

Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study
by: Yukio Kadokawa, et al.
Published: (2023-02-01)